摘要 |
<p>The present invention relates to an antibody, or fragment thereof that is specific for fibroblast growth factor receptor (FGFR)-1(IIIb), FGFR-1(IIIc), and/or FGFR-4(IIIc). The present invention further provides methods of antagonizing and neutralizing FGFR-1 and/or FGFR-4 as a treatment for obesity, diabetes, and/or a condition related thereto, including reducing food intake or total body mass.</p> |